The role of FOLFOXIRI in chemorefractory metastatic colorectal cancer patients

Introduction: The use of FOLFOXIRI (oxaliplatin, irinotecan, leucovorin, and 5-fluorouracil) as first-line therapy for metastatic colorectal cancer (mCRC) is well-established. However, there is no data about the effectiveness of this regimen in pretreated patients in the current literature. In this...

Full description

Bibliographic Details
Main Authors: Ibrahim Yildiz, Halil Taskaynatan, Umut Varol, Tarik Salman, Utku Oflazoglu, Yasar Yildiz, Yuksel Kucukzeybek, Ahmet Alacacioglu, Mustafa Oktay Tarhan
Format: Article
Language:English
Published: Turkiye Klinikleri 2018-04-01
Series:Journal of Oncological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S2452336417301310